New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressur... (LY. Structure and function of resistance...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> TECHNOLOGY

New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering

Date:6/16/2008

LY. Structure and function of resistance arteries

of hypertensive patients treated with a beta-blocker or a calcium

channel antagonist. J Hypertens 1996;14:1247-55

12. Schiffrin EL. Remodeling of resistance arteries in essential

hypertension and effects of antihypertensive

treatment. Am J Hypertens 2004;17:1192-200

13. http://www.americanheart.org/presenter.jhtml?identifier=4621 Site

accessed 4/18/2008

14. High Blood Pressure; Why Should I Care.

http://www.americanheart.org/presenter.jhtml?identifier=2129 Site

accessed 6/3/2008

15. Lewis, EJ. The Role of Angiotensin II Receptor Blockers in Preventing

the Progression of Renal Disease in Patients with Type 2 Diabetes. Am

J Hypertension 2002;15;123S-8S

16. Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal

and cardiovascular outcomes in patients with type 2 diabetes and

nephropathy. N Engl J Med 2001;345:861-9.

17. Dahlof B, Pennert K, Hansson L. Reversal of left ventricular

hypertrophy in hypertensive patients. A metaanalysis of 109 treatment

studies. Am J Hypertens 1992;5:95-110.

18. Dahlof B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity

and mortality in the Losartan Intervention For Endpoint Reduction in

Hypertension Study (LIFE): a randomized trial against atenolol. Lancet

2002;359:995-1003.

19. Smith, Ronalde et al. "Reversal of vascular hypertrophy in

hypertensive patients through blockade of angiotensin II receptors.

J Am Soc Hypertension 2008;2(3);165-172

20. Smith, Ronalde et al. "Reversal of vascular hypertrophy in

hypertensive patients through blockade of angiot
'/>"/>

SOURCE Daiichi Sankyo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3 4 5 6 7 8 9
Related medicine technology :

1. Patients Taking Cymbalta(R) Reported Reduced Pain Severity of Osteoarthritis of the Knee in New Study
2. NicOx Announces Blood Pressure Analysis From 301 Phase 3 Study for Naproxcinod at EULAR
3. Pharmaxis Long-Term Safety Study of Bronchitol Completes
4. Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers Diarrhea Vaccine
5. The New England Journal of Medicine Publishes Study Investigating the Safety and Efficacy of Baxters Cell-Based Pandemic, Avian Flu Vaccine
6. Morria Biopharmaceuticals Plc Announces Regulatory Approval to Commence Phase II Clinical Study of MRX-4 in Allergic Rhinitis
7. Genmab A/S - Company Announcement Ofatumumab in Subcutaneous Study in Rheumatoid Arthritis Summary: Subcutaneous Administration of Ofatumumab Investigated in Phase I/II Study
8. Video: Clinical Study Shows Liraglutide Reduced Blood Sugar, Weight, and Blood Pressure in Patients with Type 2 Diabetes
9. Results From One-Year Study Suggest Advair(R) Provides Important Benefits for African American Patients With Asthma
10. NeurogesX Announces Publication of NGX-4010 Phase 3 HIV-Neuropathy Study Results in Neurology
11. Banner Alzheimers Institute and Sun Health Research Institute Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimers Disease

Post Your Comments:

(Date:5/21/2013)... , May 21, 2013 /PRNewswire-iReach/ -- The 2013 ... NJ has attracted the greatest number of "Emerging" ... President, Mark Alexay . "No ... to attend this year. The show,s still 4 months ... companies. This is a big surprise and great ...

(Date:5/21/2013)... , May 21, 2013 Decision ... and advisory firms for pharmaceutical and healthcare ... emerging agent on key efficacy endpoints, including ... has the most influence over surveyed U.S. ... hormone-receptor (HR-) positive, HER2-negative breast cancer. The ...

(Date:5/21/2013)... , May 21, 2013 IsoRay, Inc. (AMEX: ... it has entered into an exclusive international distribution agreement ... product line in Greece . IsoRay ... brachytherapy and medical radioisotope applications for brain cancer, lung ... ("gyn") cancer. IASIS Medical is ideally ...

Breaking Medicine Technology:Emerging Pharma at ChemOutsourcing 2013 in Record Numbers for Upcoming September Show 2 Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer 2 IsoRay Announces A New International Distributor For Greece 2 IsoRay Announces A New International Distributor For Greece 3

[0] Emerging Pharma at ChemOutsourcing 2013 in Record Numbers for Upcoming September Show [0] Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer [0] IsoRay Announces A New International Distributor For Greece

... , , BERLIN ... NKTR ) presented favorable data today on lead oncology program, ... investigational compound in ovarian cancer. These data were presented at ... Oncology (ESMO) 2009 Joint Multidisciplinary Congress in Berlin, Germany. , ...

... , , , ... a Phase II trial of regorafenib (BAY 73-4506), a potent oral multi-kinase ... partial response rate and 50 percent stabilization rate in patients with metastatic ... at the joint 15th Congress of the European CanCer Organisation and 34th ...

Cached Medicine Technology:NKTR-102 Shows Encouraging Anti-Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplinary Congress 2 NKTR-102 Shows Encouraging Anti-Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplinary Congress 3 NKTR-102 Shows Encouraging Anti-Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplinary Congress 4 NKTR-102 Shows Encouraging Anti-Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplinary Congress 5 Bayer's Novel Anti-Cancer Compound Regorafenib (BAY 73-4506) Showed Stabilization or Regression in 81 Percent of Kidney Cancer Patients 2 Bayer's Novel Anti-Cancer Compound Regorafenib (BAY 73-4506) Showed Stabilization or Regression in 81 Percent of Kidney Cancer Patients 3 Bayer's Novel Anti-Cancer Compound Regorafenib (BAY 73-4506) Showed Stabilization or Regression in 81 Percent of Kidney Cancer Patients 4

NKTR-102 Shows Encouraging Anti-Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplinary Congress Bayer's Novel Anti-Cancer Compound Regorafenib (BAY 73-4506) Showed Stabilization or Regression in 81 Percent of Kidney Cancer Patients

(Date:5/21/2013)... 21, 2013 Heritage Woods of Dwight ... affordable assisted living community, is hosting a Quality Home Health ... 2 p.m. on Tuesday, May 28. , The community, which ... older adults of all incomes, including those on Medicaid, who ... program is open to the public. There is no ...

(Date:5/21/2013)... the George Washington (GW) University School of ... the launch of the Avance Center for ... between SPHHS, the Maryland Multicultural Youth Centers, ... This university-community partnership aims to address public ... through research, mutual capacity building and prevention ...

(Date:5/21/2013)... 2013 Patients of Dr. Michael Shenk and ... teeth due to gum disease and would like permanent tooth ... treatment with laser gum surgery. Gum disease must ... success rate out of all tooth replacement options. , ... new procedure cleared by the Food and Drug Administration (FDA) ...

(Date:5/21/2013)... LEAWOOD, Kan. Primary care practice transformation on ... health care reform efforts aimed at achieving better ... Amid emerging evidence that transformation toward the patient-centered ... today,s health care environment, the U.S. Department of ... and Quality funded 14 studies to learn more ...

(Date:5/21/2013)... York (PRWEB) May 21, 2013 Parker ... the rights of victims injured by defective medical devices, ... Bone & Joint Surgery on May 15, 2013. The ... used to identify complications that occur in patients with ... of failure. ( http://www.jbjs.org/article.aspx?articleid=1684770 ) , ...

Breaking Medicine News(10 mins):Health News:Heritage Woods of Dwight Affordable Assisted Living to Host Informational Program on the Do's and Don'ts of Arthritis 2 Health News:GW launches center to address health disparities in the Latino immigrant community 2 Health News:GW launches center to address health disparities in the Latino immigrant community 3 Health News:Shenk Dental Care Stimulates Bone Growth for Gum Disease Patients Seeking Dental Implants with Laser Gum Surgery in Atlanta, GA 2 Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 2 Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 3 Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 4 Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 5 Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 6 Health News:Parker Waichman LLP Comments on New Study Showing that MRI is Useful for Predicting Failure of Metal-on-Metal Hip Implants 2 Health News:Parker Waichman LLP Comments on New Study Showing that MRI is Useful for Predicting Failure of Metal-on-Metal Hip Implants 3

[0] Heritage Woods of Dwight Affordable Assisted Living to Host Informational Program on the Do's and Don'ts of Arthritis [0] GW launches center to address health disparities in the Latino immigrant community [0] Shenk Dental Care Stimulates Bone Growth for Gum Disease Patients Seeking Dental Implants with Laser Gum Surgery in Atlanta, GA [0] AHRQ-funded journal supplement offers lessons on primary care practice transformation [0] Parker Waichman LLP Comments on New Study Showing that MRI is Useful for Predicting Failure of Metal-on-Metal Hip Implants

... Hospital,of Chicago (NOHC) is among the top five percent in ... Hospital Quality in,America study. The HealthGrades Research analyzed patient outcomes ... The study also,concluded that NOHC is:, -- ... A recipient of the HealthGrades Spine Surgery Excellence Award ...

... Facility is First New Maine Hospital in ... Global Med Technologies(R),Inc. (OTC Bulletin Board: GLOB), ... today that its Wyndgate,Technologies(R) division has signed ... of Brunswick, Maine, to license its SafeTrace ...

... between NanoHorizons and Hill-Rom delivers patient support ... with revolutionary antimicrobial technology, BATESVILLE, Ind., ... announced an agreement to incorporate,NanoHorizon,s antimicrobial technology ... be branded as "nanoAg+ (TM) with,SmartSilver(TM)", will ...

... new guideline on colorectal cancer screening released today ... of health care organizations, including the American College ... Endoscopy (ASGE) and the American Cancer Society (ACS), ... detection and states a strong preference for screening ...

... Naval Medical Center in Bethesda, Maryland Coincides, With Sleep Apnea ... ... Awareness Week, DALLAS, March 6 /PRNewswire/ - The observance ... for Dr. Keith Thornton,third-generation Dallas dentist and recognized expert on the treatment ...

... General Nutrition Centers, Inc.,("GNC" or the "Company"), the ... its financial results for the,quarter and year ended ... is an indirect wholly-owned subsidiary,of GNC Parent LLC, ... affiliates of,Ares Management LLC and Ontario Teachers, Pension ...

Neurologic & Orthopedic Hospital of Chicago Ranked Among Top in Nation for Spine Surgery Newest Hospital in New England Signs Agreement With Global Med Technologies(R), Inc.Hill-Rom Selects NanoHorizons to Provide Antimicrobial Protection for Hill-Rom Products Using Nanotechnology New guidelines update recommendations on colorectal cancer screening Dallas Dentist Trains Navy Dentists on New Therapy to Treat Snoring and Obstructive Sleep Apnea General Nutrition Centers, Inc. Reports Fourth Quarter and Full Year 2007 Results

... The CritSpin whisper quiet, compact system ... clinic anywhere fast, accurate and cost effective ... Digital Reader, the CritSpin System offers a ... spin, complete cell packing - Meets NCCLS ...

... light over one smooth pulse duration, rather ... damage skin) that other technologies use. Palomar's ... water supply through the StarLux handpiece, down ... to as low as 4 degrees C. ...

Used to provide drainage of urine from the bladder. All-silicone construction provides maximum softness and biocompatibility for enhanced patient comfort. Supplied sterile in peel-open packages. Inte...

Used for stenting the urethra during hypospadias or epispadias repair and to promote postoperative drainage of the bladder. Supplied sterile in peel-open packages. Intended for one-time use....

Medicine Products:

CritSpin Microhematocrit Centrifuge StarLux Pulsed Light and Laser System Silicone Foley Silicone Universal Drainage Stents